https://www.proactive investors.com.au/companies/news/961630/chimeric-therapeutics-has-chm-1101-data-accepted-for-prestigious-society-for-neuro-oncology-annual-meeting-961630.html (left space in link)
Only noticed todays announcement now. Not market-sensitive. Hmmm. This takes the guesswork out of when we will hear just how good CHM-1101 is..Chimeric Therapeutics Ltd (ASX:CHM), a clinical-stage cell therapy company, has had two CHM 1101 (CLTX CAR T) abstract presentations accepted for the 26th annual Society for Neuro-Oncology (SNO) scientific meeting to be held November 18-21, 2021.
Clinical evaluation of the initial dose cohort in the phase 1 clinical trials for CHM 1101 (CLTX CAR T) will be presented on Friday, November 19, within abstract CTIM-29.
This presentation will provide new information on the safety, efficacy and bioactivity of CHM 1101 in patients treated at the initial low dose level of 44 X 106 cells with intratumoral administration in the ongoing phase 1 clinical trial.
Abstract EXTH-10, to also be presented on Friday, November 19, will provide further insight into the mechanism by which CHM 1101 (CLTX CAR T) recognises glioblastoma tumour cells.
Note: they confirm the inclusion of the intratumoral administration..
How good is this management and their communication! A1 Professionalism in all they do..
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $20.21K | 5.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2213046 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13563373 | 20 |
View Market Depth
| Last trade - 15.01pm 24/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |